Is CMPS or CNTB more undervalued in 2026?

CirclFi compares COMPASS Pathways Plc - American (CMPS) and Connect Biopharma Holdings Limi (CNTB) using 13 institutional-grade valuation models. CMPS has a Quality of Company score of 1.9/10 while CNTB scores 5.1/10.

Which is a better buy — CMPS or CNTB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CMPS and CNTB valuations compare?

CMPS at $13.06 and CNTB at $2.49 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CMPS vs CNTB Valuation Comparison 2026 — Intrinsic Value Analysis

CMPS

Pharmaceutical Preparations

COMPASS Pathways Plc - American

Quality

1.9

out of 10

Value Trap

SAFE

Price

$13.06

Last close

Models

9/13

Active

CNTB

Pharmaceutical Preparations

Connect Biopharma Holdings Limi

Quality

5.1

out of 10

Value Trap

SAFE

Price

$2.49

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	CMPS Fair Value	CMPS Upside	CNTB Fair Value	CNTB Upside
Bayesian DCF	Intrinsic	$2.95	-77.4%	$1.06	-57.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.47	-95.5%	$0.85	-65.8%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$14.06	+24.7%	—	—

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CMPS vs CNTB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CMPS vs CNTB — Which Stock Is More Undervalued?

CNTB scores higher with a 5.1/10 quality rating vs CMPS's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing COMPASS Pathways Plc - American (CMPS) and Connect Biopharma Holdings Limi (CNTB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CMPS currently trades at $13.06 with a QOC of 1.9/10, while CNTB trades at $2.49 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).